Liver Targeting Selectivity

Liver Targeting Selectivity is a pharmacokinetic metric that quantifies the preferential accumulation of a drug or therapeutic agent in the liver relative to other tissues, distinguishing it by its specificity for hepatic partitioning over systemic or off-target distribution.

68

Publications

3.1K

Citations

498

Authors

131

Institutions

Publications per year

2017–2026

23

Authors

498

  1. YT
    Yasuhiko Tabata

    Kyoto University, Japan

    6 publications · 451 citations

    6

    h-index

  2. YI
    Yoshito Ikada

    Kyoto University, Japan

    4 publications · 154 citations

    4

    h-index

  3. MD
    Mark D. Erion

    Torrey Pines Institute For Molecular Studies, United States

    4 publications · 101 citations

    4

    h-index

  4. RZ
    Ruizhi Zhao

    Guangzhou University of Chinese Medicine, China

    4 publications · 61 citations

    4

    h-index

  5. LL
    Lijuan Liu

    Hong Kong Baptist University, Hong Kong SAR China

    3 publications · 50 citations

    3

    h-index

1–5 of 498

Venues

  1. PubMed

    Repository · 4 publications · 126 citations

    4

    h-index

  2. International Journal of Pharmaceutics

    4 publications · 530 citations

    4

    h-index

  3. Pharmaceutical Research

    3 publications · 119 citations

    3

    h-index

  4. Journal of Controlled Release

    3 publications · 193 citations

    3

    h-index

  5. AAPS PharmSciTech

    2 publications · 86 citations

    2

    h-index

1–5